Inside Big Pharma's $70M Drug Pricing War In Calif.

Law360, New York (June 8, 2016, 8:22 PM EDT) -- Top pharmaceutical companies have earmarked nearly $70 million to defeat a high-stakes ballot measure that would cap prescription drug prices in California, and experts say the outcome will reverberate from coast to coast in the nation's searing debate over drug innovation and affordability.

Here's what you need to know about Proposition 61, which made the Nov. 8 ballot after its proponent, the Los Angeles-based AIDS Healthcare Foundation, gathered 400,000 valid signatures from state residents.

What Would the Measure Do?

The measure, known as the California Drug...
To view the full article, register now.